Clinical Trials Browser

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

Lung Neoplasms, Neoplasm, Residual

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Neoplasm, Residual

Neoplasm, Residual

Prostatic Neoplasms, Neoplasm, Residual

Neoplasm, Residual, Neoplasms, Plasma Cell

Leukemia, Myeloid, Acute, Neoplasm, Residual

Neoplasm, Residual

Leukemia, Myeloid, Acute, Neoplasm, Residual

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm, Residual

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

Waldenstrom Macroglobulinemia, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Neoplasm, Residual

Colonic Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Neoplasm, Residual

Neoplasm, Residual

Neoplasm, Residual

Colorectal Neoplasms, Neoplasm, Residual

Skin Neoplasms, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Breast Neoplasms, Neoplasm, Residual

Neoplasm, Residual, Small Cell Lung Carcinoma

Leukemia, Myeloid, Acute, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Carcinoma, Hepatocellular, Recurrence, Neoplasm, Residual

Colorectal Neoplasms, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Colorectal Neoplasms, Neoplasm, Residual

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm, Residual

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Recurrence, Neoplasm, Residual

Rectal Neoplasms, Neoplasm, Residual

Endometrial Neoplasms, Neoplasm, Residual

Esophageal Neoplasms, Neoplasm, Residual

Neoplasm, Residual, Gastrointestinal Stromal Tumors

Biliary Tract Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

Neoplasms, Neoplasm, Residual

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Neoplasm, Residual, Gastrointestinal Stromal Tumors

Multiple Myeloma, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Neoplasm, Residual

Neoplasm, Residual

Clinical Trials

TRACE-BTC

To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

EURHOLY

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

NIRVANA

FERTILAM

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

DUALFLOW

Clear-HPVca

HER2 CR

FIL_BIOWM

Risk-adapted Therapeutic Strategy in +1q NDMM

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

NIP IT!

BRALLA

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer

CR1STAL

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

ctDNA in Cutaneous Squamous Cell Carcinoma

MRD-CONFIRM

Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

MRD

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

SCAN-B

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

ctDNA-endo

ECMRD-001

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

MARTINI

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

ctDNA Methylation Sequencing for Myeloma

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma

MMRD

Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC

Validation of a Score That Predicts Residual Disease in Incidental Gallbladder Cancer

VMRDO